What are the most common mistakes with HGH (Somatropin)?
The most common HGH (Somatropin) mistakes are treating it like a peptide with low oversight, it isn't; underestimating the legal/regulatory risk; stacking with other things that raise insulin resistance. Most issues people run into come down to protocol and expectations, not the compound itself. Going in informed matters here because human evidence for HGH (Somatropin) is limited.
Common HGH (Somatropin) mistakes
- Treating it like a peptide with low oversight, it isn't
- Underestimating the legal/regulatory risk
- Stacking with other things that raise insulin resistance
Bloodwork worth tracking
- IGF-1
- Fasting glucose / A1C
- TSH / fT4
- ALT/AST
References
- Growth Hormone Treatment in Adults with Growth Hormone Deficiency (clinical practice guideline) — Molitch ME et al., JCEM, 2011
- The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency — Salomon F, Cuneo RC, Hesp R, et al., New England Journal of Medicine, 1989
- Effects of human growth hormone in men over 60 years old — Rudman D, Feller AG, Nagraj HS, et al., New England Journal of Medicine, 1990
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on HGH (Somatropin)
Full HGH (Somatropin) breakdownHGH (Somatropin) what it's used forHGH (Somatropin) side effectsHGH (Somatropin) how to take itHGH (Somatropin) who should avoid itHGH (Somatropin) half-lifeHGH (Somatropin) how long to workHGH (Somatropin) legal statusHGH (Somatropin) how it workshgh vs sermorelinhgh vs mk 677hgh vs tesamorelinAsk the AI Coach
Last updated 2026-06-15.